These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome]. Kujawa A, Rózycki R. Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939 [Abstract] [Full Text] [Related]
7. The scientific context and basis of the pharmacologic management of dry eyes. Gilbard JP. Ophthalmol Clin North Am; 2005 Dec; 18(4):475-84, v. PubMed ID: 16314213 [Abstract] [Full Text] [Related]
10. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Russo PA, Bouchard CS, Galasso JM. Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749 [Abstract] [Full Text] [Related]
11. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Wilson SE, Perry HD. Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588 [Abstract] [Full Text] [Related]
12. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Yoon KC, Jeong IY, Im SK, Park YG, Kim HJ, Choi J. Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430 [Abstract] [Full Text] [Related]
15. Ophthalmic cyclosporine use in ocular GVHD. Lelli GJ, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI. Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652 [Abstract] [Full Text] [Related]
16. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Ogawa Y, Okamoto S, Kuwana M, Mori T, Watanabe R, Nakajima T, Yamada M, Mashima Y, Tsubota K, Oguchi Y. Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336 [Abstract] [Full Text] [Related]